Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$4,370,723
+$1,243,505 QoQ
Shares Held
3,644
+7.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.42%
of 13F equity value
Holder Rank
#1,820
of 4,621 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DeDora Capital, Inc. holds $14,607,227 across 7 Drug Manufacturers - General names. LLY ranks #1 (29.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,644 | $4,370,723 | |
| 2 | ABBV |
AbbVie Inc.
|
15,149 | $3,812,094 | |
| 3 | AMGN |
Amgen Inc
|
7,475 | $2,706,847 | |
| 4 | JNJ |
Johnson & Johnson
|
6,554 | $1,664,519 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,956 | $1,279,346 | |
| 6 | AZN |
Astrazeneca PLC
|
2,226 | $422,094 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,783 | $351,604 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,370,723 | 3,644 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $3,127,218 | 3,400 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,664,659 | 3,410 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,372,167 | 3,109 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,331,574 | 2,991 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,277,859 | 2,758 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,930,772 | 2,501 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,221,051 | 2,507 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,028,051 | 2,240 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,674,169 | 2,152 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,035,848 | 1,777 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $930,309 | 1,732 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $657,509 | 1,402 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $246,232 | 717 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $329,621 | 901 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $349,541 | 1,081 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $350,168 | 1,080 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $304,697 | 1,064 | Shares | Sole | 2022-04-14 | |
| 2021-09-30 | $262,934 | 1,138 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $279,325 | 1,217 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $234,272 | 1,254 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $211,218 | 1,251 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||